tirzepatide vs semaglutide review weight loss efficacy comparison Comparative and safety of 2.4 mg and 5–15 red rock pharmacy tirzepatide reviews

Following lead-in, eligible participants were randomized (1:1) to 12 weeks of tirzepatide (15 mg) followed by 12 weeks of placebo or vice versa ( Figure 1A )

SURMOUNT-2 key efficacy results, source: reference [2] Tirzepatide also met all key secondary endpoints, including reductions in A1C and other cardiometabolic parameters

Moreover, the SURPASS-CVOT trial (NCT04255433) will assess the non-inferiority of tirzepatide against dulaglutide 1.5 mg on cardiovascular safety in people with T2D and established cardiovascular disease (expected completion date June 2025) [Citation68]

Branded Tirzepatide vs

DPP-4 = dipeptidyl peptidase-4